RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway
Oxidative Medicine and Cellular Longevity · 2023
DOI: 10.1155/2023/1728463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2023. Verfasst von Hao Hua und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatic-Biliary-Pancreatic Surgery, The Affiliate Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Proto-Oncogene Proteins c-akt, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Planning Project of Guizhou Province, Science and Technology Foundation of Health and Family Planning Commission of Guizhou Province, Science and Platform Talent of Guizhou Province.
Abstract (Originalsprache)
RING finger protein-7 (RNF7) functions as a positive regulator in the progression of multiple malignancies. However, the underlying mechanism by which RNF7 contributes to pancreatic cancer (PC) is lacking. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to test the level of RNF7expression in PC cell lines and tissues. The role of RNF7 in PC tumorigenesis was analyzed by Cell Counting Kit-8 (CCK-8). 5-Ethynyl-20-deoxyuridine (EdU), wound-healing/Transwell assays, as well as a subcutaneous tumorigenesis model were constructed to assess the role of RNF7 in PC cells. The association between RNF7 and PI3K/Akt signaling were assessed by western blot and further confirmed by rescue experiments. The PC patients with upregulated expression of RNF7 had poor survival. Overexpression of RNF7 significantly facilitated PC proliferative and migrative and invasive properties in vitro and vivo; however, knockdown of RNF7exhibited the opposite results. Mechanistically, RNF7 promoted PANC-1 and SW1990 cell growth through impacting the activation of the PI3K/Akt signaling pathway. Our data demonstrated that RNF7 promoted PC tumorigenesis via activating the PI3K/Akt signaling pathway and might be regarded as one of the potential therapies to PC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hepatic-Biliary-Pancreatic Surgery, The Affiliate Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- School of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou, China.
Förderung
- Science and Technology Planning Project of Guizhou Province
- Science and Technology Foundation of Health and Family Planning Commission of Guizhou Province
- Science and Platform Talent of Guizhou Province
- Clinical Medical Research Center of Hepatobiliary Surgery of Guizhou Province
- Science and Technology Cooperation Support of Guizhou Province
- National Natural Science Foundation of China
Zitieren
APA
Hua, H., Xie, H., Zheng, J., Lei, L., Deng, Z., & Yu, C. (2023). RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2023/1728463
Vancouver
Hua H, Xie H, Zheng J, Lei L, Deng Z, Yu C. RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2023. doi:10.1155/2023/1728463
BibTeX
@article{Hua2023,
author = {Hua, Hao and Xie, Huahua and Zheng, Jian and Lei, Linhan and Deng, Zilei and Yu, Chao},
title = {RNF7 Facilitated the Tumorigenesis of Pancreatic Cancer by Activating PI3K/Akt Signaling Pathway},
journal = {Oxidative Medicine and Cellular Longevity},
year = {2023},
doi = {10.1155/2023/1728463}
}
EUVIMED